How will COVID-19 affect TB patients and control?
Our 2020 World TB Day Symposium has been cancelled because of the COVID-19 pandemic. Here, three experts from University College London (UCL) and the London School of Hygiene & Tropical Medicine (LSHTM) discuss the effect of the pandemic on TB patients and the TB control programme.
- Beate Kampmann is Professor of Paediatric Infection & Immunity and Director of the Vaccine Centre at the LSHTM, and leads the Vaccines & Immunity research at the MRC Unit in The Gambia, including the childhood TB research programme.
- Dr Toyin Togun is an Assistant Professor at the LSHTM and a Clinician-Scientist at the MRC Unit The Gambia at LSHTM. He leads the Childhood TB Work Package in the EDCTP-funded West African Nodes of Excellence for TB, AIDS and Malaria (WANETAM) consortium.
- Marc Lipman is Professor of Medicine at UCL, Consultant in Respiratory and HIV Medicine at the Royal Free London NHS Foundation Trust, and Director of UCL-TB, UCL’s cross-disciplinary TB research grouping.
Video - watch on YouTube: